Literature DB >> 30265599

Weaponizing Hope: Sources of Hope, Unrealistic Optimism, and Denial.

Marsha Michie1, Megan Allyse2, Katie A Stoll3, Zubin Master2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30265599      PMCID： PMC6314021          DOI： 10.1080/15265161.2018.1498946

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  6 in total

1.  Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.

Authors:  J B Hrachovec; M Mora
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

2.  Dangerous deception--hiding the evidence of adverse drug effects.

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

3.  Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.

Authors:  Leigh Turner; Paul Knoepfler
Journal:  Cell Stem Cell       Date:  2016-06-30       Impact factor: 24.633

4.  Conflicts of interest in genetic counseling: acknowledging and accepting.

Authors:  Katie A Stoll; Amanda Mackison; Megan A Allyse; Marsha Michie
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

Review 5.  Marketing of unproven stem cell-based interventions: A call to action.

Authors:  Douglas Sipp; Timothy Caulfield; Jane Kaye; Jan Barfoot; Clare Blackburn; Sarah Chan; Michele De Luca; Alastair Kent; Christopher McCabe; Megan Munsie; Margaret Sleeboom-Faulkner; Jeremy Sugarman; Esther van Zimmeren; Amy Zarzeczny; John E J Rasko
Journal:  Sci Transl Med       Date:  2017-07-05       Impact factor: 17.956

Review 6.  Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions.

Authors:  Claire Horner; Evelyn Tenenbaum; Douglas Sipp; Zubin Master
Journal:  NPJ Regen Med       Date:  2018-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.